The U.S. Food and Drug Administration (FDA) just authorized the 2023-2024 updated mRNA Moderna and Pfizer-BioNTech COVID-19 vaccines for emergency use.  These updated vaccines have been “formulated to more closely target currently circulating variants,” and “include a monovalent (single) component …

FDA Authorizes Updated COVID-19 Vaccines for Emergency Use Read more »